The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date

Antza C, Nirantharakumar K, Doundoulakis I, Tahrani AA, Toulis KA

Drug Design, Development and Therapy 2019, 13:2985-2996

Published Date: 22 August 2019